Use of the dopamine agonist cabergoline in the treatment of movement disorders

Author: Di Marco Aimee   Appiah-Kubi Linda S   Chaudhuri K Ray  

Publisher: Informa Healthcare

ISSN: 1465-6566

Source: Expert Opinion on Pharmacotherapy, Vol.3, Iss.10, 2002-10, pp. : 1481-1487

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract